Insurers warn shareholders of reputational, AI and tariff risks

Major insurers are warning shareholders about AI-related reputational damage, regulatory scrutiny, and tariff exposure in recent filings. Risks include public backlash over AI-driven claim denials and rising costs from tariffs on medical goods.

Categorized in: AI News Insurance
Published on: May 08, 2026
Insurers warn shareholders of reputational, AI and tariff risks

Insurers caution shareholders about bad PR, AI risks, tariffs

Major insurers are flagging reputational damage, regulatory scrutiny, and operational risks tied to artificial intelligence deployment in shareholder disclosures, according to recent filings reviewed by Modern Healthcare.

The warnings center on three distinct threats. First, insurers face mounting public backlash over prior authorization denials and claims decisions, particularly when those decisions involve AI systems. Second, regulators are intensifying oversight of how insurers use AI to make coverage and payment determinations. Third, tariff policies could raise operational costs and complicate supply chains.

AI and reputation collide

Insurers acknowledge that deploying AI for claims processing and underwriting carries reputational risk if systems make high-profile errors or deny coverage in ways the public perceives as unfair. Several major carriers noted that negative media coverage about AI decision-making could harm brand trust and invite regulatory action.

The concern reflects real-world pressure. States are moving to restrict prior authorization practices and scrutinize how insurers determine provider reimbursement rates. Pennsylvania has already sued an AI company over bots that allegedly posed as clinicians.

Regulatory tightening

Shareholder filings indicate insurers expect regulators to impose new rules around AI transparency and explainability. Some disclosures mention potential requirements to disclose how algorithms make coverage decisions or to allow human review of AI-driven denials.

Insurers also flagged uncertainty about whether existing insurance regulations adequately address AI-specific risks. This regulatory gap could force companies to adopt stricter internal controls before rules are formally codified.

Tariff exposure

Beyond AI, insurers cited tariff policies as a material business risk. Higher tariffs could increase costs for medical devices, pharmaceuticals, and other healthcare goods that flow through supply chains, potentially driving up claims costs.

Learn more about AI for Insurance and how these technologies are reshaping claims, underwriting, and risk assessment across the industry. You can also explore Generative AI and LLM applications to understand the specific tools insurers are deploying and the risks they carry.


Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)